Literature DB >> 18816751

Do different animal models of IBD serve different purposes?

Matthew B Grisham1.   

Abstract

Mesh：

Year:  2008        PMID： 18816751     DOI： 10.1002/ibd.20682

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

1.  Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.

Authors:  Bo Xiao; Xiaoying Si; Mingzhen Zhang; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-01       Impact factor: 5.268

2.  Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.

Authors:  Bo Xiao; Zhigang Xu; Emilie Viennois; Yuchen Zhang; Zhan Zhang; Mingzhen Zhang; Moon Kwon Han; Yuejun Kang; Didier Merlin
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

3.  Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.

Authors:  Qiubing Chen; Xiaoying Si; Lijun Ma; Panpan Ma; Meili Hou; Shuang Bai; Xiaoshuai Wu; Ying Wan; Bo Xiao; Didier Merlin
Journal:  J Mater Chem B       Date:  2017-05-05       Impact factor: 6.331

4.  Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.

Authors:  Bo Xiao; Hamed Laroui; Emilie Viennois; Saravanan Ayyadurai; Moiz A Charania; Yuchen Zhang; Zhan Zhang; Mark T Baker; Benyue Zhang; Andrew T Gewirtz; Didier Merlin
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

5.  TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.

Authors:  Bo Xiao; Qiubing Chen; Zhan Zhang; Lixin Wang; Yuejun Kang; Timothy Denning; Didier Merlin
Journal:  J Control Release       Date:  2018-08-11       Impact factor: 9.776

6.  Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.

Authors:  Bo Xiao; Zhan Zhang; Emilie Viennois; Yuejun Kang; Mingzhen Zhang; Moon Kwon Han; Jiucun Chen; Didier Merlin
Journal:  Theranostics       Date:  2016-09-25       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.